Literature DB >> 24745340

Development of a de novo arteriovenous malformation after bilateral revascularization surgery in a child with moyamoya disease.

Miki Fujimura1, Naoto Kimura, Masayuki Ezura, Kuniyasu Niizuma, Hiroshi Uenohara, Teiji Tominaga.   

Abstract

The development of a de novo arteriovenous malformation (AVM) in patients with moyamoya disease is extremely rare. A 14-year-old girl developed an AVM in the right occipital lobe during the 4-year postoperative period following successful bilateral revascularization surgeries. She suffered a transient ischemic attack with hemodynamic compromise of the bilateral hemispheres at the age of 10 years. Results of an initial examination by 1.5-T MRI and MR angiography satisfied the diagnostic criteria of moyamoya disease but failed to detect any vascular malformation. Bilateral direct and indirect revascularization surgeries in the anterior circulation relieved her symptoms, and she underwent MRI and MR angiography follow-up every year after surgery. Serial T2-weighted MRI revealed the gradual appearance of flow voids in the right occipital lobe during the follow-up period. Magnetic resonance angiography ultimately indicated the development of an AVM 4 years after these surgeries when catheter angiography confirmed the diagnosis of an AVM in the right occipital lobe. The AVM remained asymptomatic, and the patient remained free of cerebrovascular events during the time she was observed by the authors. Acquired AVM in moyamoya disease is extremely rare, with only 3 pediatric cases including the present case being reported in the literature. The development of a de novo AVM in a postoperative patient with moyamoya disease appears to be unique, and this case may provide insight into the dynamic pathology of AVMs.

Entities:  

Keywords:  AVM = arteriovenous malformation; PCA = posterior cerebral arery; arteriovenous malformation; de novo development; moyamoya disease; vascular disorders

Mesh:

Year:  2014        PMID: 24745340     DOI: 10.3171/2014.3.PEDS13610

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  7 in total

1.  Review of de novo cerebral arteriovenous malformation: haemorrhage risk, treatment approaches and outcomes.

Authors:  Xianli Lv; Guihuai Wang
Journal:  Neuroradiol J       Date:  2018-02-22

2.  Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Authors:  Sherif Rashad; Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

3.  Cerebral arteriovenous malformation associated with moyamoya disease.

Authors:  Jung-Hoon Noh; Je Young Yeon; Jae-Han Park; Hyung Jin Shin
Journal:  J Korean Neurosurg Soc       Date:  2014-10-31

4.  De Novo Arteriovenous Malformation after Aneurysm Clipping.

Authors:  Satoka Shidoh; Masahito Kobayashi; Kazunori Akaji; Tadashige Kano; Yoshio Tanizaki; Ban Mihara
Journal:  NMC Case Rep J       Date:  2017-06-08

Review 5.  'De Novo' Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases.

Authors:  Ioan Alexandru Florian; Lehel Beni; Vlad Moisoiu; Teodora Larisa Timis; Ioan Stefan Florian; Adrian Balașa; Ioana Berindan-Neagoe
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

6.  Intraoperative Early Venous Filling Phenomenon as an Intrinsic Sign of the Local Hemodynamic Change after Revascularization Surgery in a Patient with Adult Moyamoya Disease: Implications of a Potential Arteriovenous Shunt.

Authors:  Kikutaro Tokairin; Taku Sugiyama; Masaki Ito; Miki Fujimura
Journal:  NMC Case Rep J       Date:  2021-11-02

7.  Moyamoya disease associated with arteriovenous malformation and anterior communicating artery aneurysm: A case report and literature review.

Authors:  Jinlu Yu; Yongjie Yuan; Duoduo Zhang; Kan Xu
Journal:  Exp Ther Med       Date:  2016-04-21       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.